Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

January 19, 2007 09:00 ET

Meridian Signs Memorandum of Understanding for the Exclusive Distribution of its Lapex 2000 LipoLaser in a leading Pacific Rim Country

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Jan. 19, 2007) - Meridian Co., Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that it has entered into a memorandum of understanding ("MOU") with a Pacific Rim-based aesthetic equipment importer ("Importer") for the exclusive marketing and distribution of Meridian's Lapex 2000 LipoLaser in a specific Pacific Rim country.

The MOU outlines the general terms of a definitive distribution agreement that would grant the Importer an exclusive right to market and distribute the Lapex 2000 LipoLaser for a large Pacific Rim country. While the Importer has not committed to firm orders, to keep the exclusivity portion of the distribution agreement, it must purchase units that at present terms and conditions would result in US$6 million in sales over the first 12-months of the agreement.

In consideration of signing the MOU, the distributor has advanced a non-refundable deposit of US$50,000. The Company expects the definitive agreement will be executed with 30 days.

More About the Lapex 2000 LipoLaser:

The Lapex 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address body shaping/contouring, spot fat reduction, and reduction in the appearance of cellulite. The Lapex 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat those stubborn areas of fat that have not responded to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but in any clinical setting such as spas and wellness centers that treat localized body fat deposits which may not have responded to diet and exercise.

Light-based treatments are now the mainstays of medical aesthetic practices. These treatments earned more than $8 billion for practitioners and almost $550 million for equipment manufacturers. By 2009, this is expected to grow to over 84 million treatments annually earning practitioners $13.9 billion and manufacturers nearly $1 billion.

More About: Meridian Co. Ltd.

Meridian is an established leader in the research/development, manufacturing and sales of integrative medical equipment. The Company sells its products and equipment to a wide range of customers in the global health care industry. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval, as well as other international regulatory approvals, for many of its products.

On Behalf of the Board of Directors, Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contact Information